Literature DB >> 16050006

JBMR anniversary classic. Nitrogen-containing biophosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. Originally published in Volume 7, number 4, pp 581-9 (1998).

Steven P Luckman, David E Hughes, Fraser P Coxon, Graham G Russell, Michael J Rogers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16050006     DOI： 10.1359/jbmr.2005.20.7.1265

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN： 0884-0431            Impact factor:   6.741


× No keyword cloud information.
  3 in total

1.  The impact of bisphosphonates on the osteoblast proliferation and Collagen gene expression in vitro.

Authors:  Felix Peter Koch; Sareh Said Yekta; Christina Merkel; Thomas Ziebart; Ralf Smeets
Journal:  Head Face Med       Date:  2010-07-09       Impact factor: 2.151

2.  In Vivo Bone Effects of a Novel Bisphosphonate-EP4a Conjugate Drug (C3) for Reversing Osteoporotic Bone Loss in an Ovariectomized Rat Model.

Authors:  Zeeshan Sheikh; Gang Chen; Faik Al-Jaf; Marion Thévenin; Kate Banks; Michael Glogauer; Robert N Young; Marc D Grynpas
Journal:  JBMR Plus       Date:  2019-11-09

3.  Alendronate inhibits VEGF expression in growth plate chondrocytes by acting on the mevalonate pathway.

Authors:  K D Evans; A M Oberbauer
Journal:  Open Orthop J       Date:  2009-10-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.